CTNM
NASDAQ · Pharmaceuticals
Contineum Therapeutics Inc-A
$13.20
+0.38 (+2.96%)
Open$13.21
Previous Close$12.82
Day High$13.90
Day Low$12.69
52W High$16.33
52W Low$3.35
Volume—
Avg Volume239.7K
Market Cap567.01M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+194.1% upside
Current
$13.20
$13.20
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 273.32M | 248.64M | 220.16M |
| Net Income | 33.71M | 25.85M | 22.01M |
| Profit Margin | 12.3% | 10.4% | 10.0% |
| EBITDA | 45.63M | 48.42M | 37.59M |
| Free Cash Flow | 26.06M | 26.05M | 25.67M |
| Rev Growth | -0.8% | +22.0% | +2.7% |
| Debt/Equity | 0.64 | 0.69 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |